DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Levoxyl (Levothyroxine) - Adverse Event Reports - Hospitalization - Condition Aggravated

 


Nutrilib.com
A comprihensive source of nutritional information

Index of reports > Cases resulting in hospitalization (8) > Cases with Condition Aggravated (2)

Below is the selection of adverse event reports related to Levoxyl (Levothyroxine). that includes cases resulting in hospitalization where reactions include condition aggravated.

Adverse event in female receiving Levoxyl (Levothyroxine)

Reported by a consumer/non-health professional from United States on 2007-05-02

Patient: female, weighing 99.8 kg (219.6 pounds)

Adverse reactions / side effects: Back Pain, Cellulitis, Joint Swelling, Alopecia, Condition Aggravated, Atrial Fibrillation, Thyroid Disorder, Bone Disorder

Adverse event resulted in: hospitalization

Suspect drug(s):
Norvasc
    Administration route: Oral
    Indication: Hypertension
    Start date: 2004-06-01
    End date: 2004-11-01

Tikosyn
    Dosage: freq:bid interval: every day
    Administration route: Oral
    Indication: Atrial Fibrillation

Levoxyl
    Dosage: freq:unknown
    Administration route: Oral

Other drugs received by patient: Toprol-XL; Zetia; Clonidine; Warfarin Sodium; Hytrin; Demadex; Avapro; Digoxin



Adverse event in female receiving Levoxyl (Levothyroxine)

Reported by a individual with unspecified qualification from United States on 2007-03-26

Patient: female, weighing 85.0 kg (187.0 pounds)

Adverse reactions / side effects: Insomnia, Condition Aggravated

Adverse event resulted in: hospitalization

Suspect drug(s):
Femara

Levoxyl
    Dosage: 58 mcg daily

Other drugs received by patient: Ambien; Aspirin; Benicar; Centrum Silver; Doxazosin Mesylate; Effexor; Klor-CON; Lipitor; Naprosyn; Nexium

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008